Hologic (HOLX) Falls More Steeply Than Broader Market: What Investors Need to Know

In the latest trading session, Hologic (HOLX) closed at $71.74, marking a -0.49% move from the previous day. The stock fell short of the S&P 500, which registered a loss of 0.22% for the day. Elsewhere, the Dow lost 0.36%, while the tech-heavy Nasdaq lost 0.16%.Heading into today, shares of the medical device maker had lost 6.22% over the past month, outpacing the Medical sector's loss of 6.83% and lagging the S&P 500's loss of 2.36% in that time.Analysts and investors alike will be keeping a close eye on the performance of Hologic in its upcoming earnings disclosure. It is anticipated that the company will report an EPS of $1.01, marking a 3.06% rise compared to the same quarter of the previous year. Meanwhile, our latest consensus estimate is calling for revenue of $1.03 billion, up 1.39% from the prior-year quarter.For the annual period, the Zacks Consensus Estimates anticipate earnings of $4.29 per share and a revenue of $4.17 billion, signifying shifts of +5.15% and +3.53%, respectively, from the last year.Investors might also notice recent changes to analyst estimates for Hologic. These revisions help to show the ever-changing nature of near-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the company's business health and profitability.Based on our research, we believe these estimate revisions are directly related to near-team stock moves. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 0.04% higher. Hologic is currently a Zacks Rank #3 (Hold).Valuation is also important, so investors should note that Hologic has a Forward P/E ratio of 16.82 right now. This denotes a discount relative to the industry's average Forward P/E of 26.77.We can additionally observe that HOLX currently boasts a PEG ratio of 2.45. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. Medical - Instruments stocks are, on average, holding a PEG ratio of 2 based on yesterday's closing prices.The Medical - Instruments industry is part of the Medical sector. This group has a Zacks Industry Rank of 71, putting it in the top 29% of all 250+ industries.The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.Just Released: Zacks Top 10 Stocks for 2024Hurry – you can still get in early on our 10 top tickers for 2025. Handpicked by Zacks Director of Research Sheraz Mian, this portfolio has been stunningly and consistently successful. From inception in 2012 through November, 2024, the Zacks Top 10 Stocks gained +2,112.6%, more than QUADRUPLING the S&P 500’s +475.6%. Sheraz has combed through 4,400 companies covered by the Zacks Rank and handpicked the best 10 to buy and hold in 2025. You can still be among the first to see these just-released stocks with enormous potential. See New Top 10 Stocks >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Hologic, Inc. (HOLX): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks